Respiri (ASX:RSH) CEO Mario Gattino departs

09OctOctober 9, 2019

Respiri (ASX:RSH) CEO Mario Gattino departs

Respiri (ASX:RSH) CEO Mario Gattino will be leaving the medical technology company.

The Board says once arrangements have been finalised for Mr Gattino’s departure, the company will commence its search for a new CEO.

Respiri remains fully committed to delivering on the Board's strategy and meeting key milestones on time and says the company will provide further updates regarding plans for a new CEO in due course.

Shares in Respiri (ASX:RSH) are trading 16.34 per cent lower at 6c

Source: Finance News Network

24MarMarch 24, 2021

Genex Power (ASX:GNX) executes connection agreement with Powerlink

23 Mar 2021 - Genex Power (ASX:GNX) has finalised its negotiations with Powerlink Queensland in relation to the connection arrangements for the 250MW Kidston Pumped Storage Hydro Project.

10MarMarch 10, 2021

Treasury Wine Estates (ASX:TWE) reaches a long-term agreement with The Wine Group

10 Mar 2021 - Treasury Wine Estates (ASX:TWE) has reached an agreement with The Wine Group in relation to several of TWE’s commercial tier brands from its US portfolio.

16JanJanuary 16, 2020

Company Secretary appoinment at Centaurus Metals (ASX:CTM)

16 Jan 2020 - Centaurus Metals (ASX:CTM) appoints Company Secretary.

08AprApril 8, 2021

News Corp (ASX:NWS) launches US$750 million private offering of senior notes

08 Apr 2021 - Diversified media and information company News Corp (ASX:NWS) is to raise US$750 million in a private offering of senior notes due in 2029.

16MarMarch 16, 2021

Starpharma (ASX:SPL) reports DEP HER2-lutetium shows potent anticancer effect

16 Mar 2021 - Starpharma (ASX:SPL) says its second radiopharmaceutical candidate, DEP HER2-lutetium, achieved potent and durable anticancer activity, with complete tumour regression, outperforming Herceptin labelled with lutetium, in a breast cancer model.